Moderna
MRNA
#937
Rank
C$29.29 B
Marketcap
$76.21
Share price
0.50%
Change (1 day)
-22.17%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Revenue for Moderna (MRNA)

Revenue in 2024 (TTM): C$6.68 Billion

According to Moderna 's latest financial reports the company's current revenue (TTM ) is C$6.95 Billion. In 2023 the company made a revenue of C$8.95 Billion a decrease over the revenue in the year 2022 that were of C$25.61 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Moderna from 2018 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) C$6.68 B-25.34%
2023 C$8.95 B-65.02%
2022 C$25.61 B13.31%
2021 C$22.60 B6360.95%
2020 C$0.34 B457.63%
2019 C$62.73 M-62.49%
2018 C$0.16 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
C$87.15 B 1,152.59%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.11 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
C$3.27 B-53.00%๐Ÿ‡บ๐Ÿ‡ธ USA
C$68.15 B 879.55%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
C$27.4 M-99.61%๐Ÿ‡บ๐Ÿ‡ธ USA
C$122.33 B 1,658.14%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.26 B-96.13%๐Ÿ‡บ๐Ÿ‡ธ USA